🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jan Irene Lloren

University of Wisconsin–Milwaukee

ORCID: 0000-0002-4854-9057

Biochemistry, Genetics and Molecular BiologyMedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?”.

Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?

Annals of Surgical Oncology(2024)10.1245/s10434-024-14914-9

N/A

0DataRank · unranked

10 citations

Jan Irene Lloren, Christine Rogers, Morgan K. Johnson, Adrienne N. Cobb, Chiang‐Ching Huang +4 more

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07750-2

N/A

0DataRank · unranked

5 citations

Christine C Rogers, Jan Irene Lloren, Sailaja Kamaraju, Lubna N. Chaudhary, Chiang‐Ching Huang +6 more

Does neoadjuvant systemic therapy in clinical T1–2 N0 human epidermal growth factor receptor 2–positive breast cancer increase the extent of axillary surgery?

Surgery(2025)10.1016/j.surg.2025.109907

N/A

0DataRank · unranked

0 citations

Lauren N. Cohen, Jan Irene Lloren, Chiang‐Ching Huang, Adrienne N. Cobb, Amanda L. Kong +4 more